Literature DB >> 19550285

HIV integration site distributions in resting and activated CD4+ T cells infected in culture.

Troy Brady1, Luis M Agosto, Nirav Malani, Charles C Berry, Una O'Doherty, Frederic Bushman.   

Abstract

OBJECTIVE: The goal of this study was to investigate whether the location of HIV integration differs in resting versus activated T cells, a feature that could contribute to the formation of latent viral reservoirs via effects on integration targeting.
DESIGN: Primary resting or activated CD4 T cells were infected with purified X4-tropic HIV in the presence and absence of nucleoside triphosphates and genomic locations of integrated provirus determined.
METHODS: We sequenced and analyzed a total of 2661 HIV integration sites using linker-mediated PCR and 454 sequencing. Integration site data sets were then compared to each other and to computationally generated random distributions.
RESULTS: HIV integration was favored in active transcription units in both cell types, but integration sites from activated cells were found more often in genomic regions that were dense in genes, dense in CpG islands, and enriched in G/C bases. Integration sites from activated cells were also more strongly correlated with histone methylation patterns associated with active genes.
CONCLUSION: These data indicate that integration site distributions show modest but significant differences between resting and activated CD4 T cells, and that integration in resting cells occurs more often in regions that may be suboptimal for proviral gene expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19550285      PMCID: PMC2862484          DOI: 10.1097/QAD.0b013e32832caf28

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  54 in total

1.  A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes.

Authors:  Anna K Thomas; Marcela V Maus; Waleed S Shalaby; Carl H June; James L Riley
Journal:  Clin Immunol       Date:  2002-12       Impact factor: 3.969

2.  HIV-1 integration in the human genome favors active genes and local hotspots.

Authors:  Astrid R W Schröder; Paul Shinn; Huaming Chen; Charles Berry; Joseph R Ecker; Frederic Bushman
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

3.  Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.

Authors:  Yefei Han; Kara Lassen; Daphne Monie; Ahmad R Sedaghat; Shino Shimoji; Xiao Liu; Theodore C Pierson; Joseph B Margolick; Robert F Siliciano; Janet D Siliciano
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

5.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.

Authors:  Salima Hacein-Bey-Abina; Alexandrine Garrigue; Gary P Wang; Jean Soulier; Annick Lim; Estelle Morillon; Emmanuelle Clappier; Laure Caccavelli; Eric Delabesse; Kheira Beldjord; Vahid Asnafi; Elizabeth MacIntyre; Liliane Dal Cortivo; Isabelle Radford; Nicole Brousse; François Sigaux; Despina Moshous; Julia Hauer; Arndt Borkhardt; Bernd H Belohradsky; Uwe Wintergerst; Maria C Velez; Lily Leiva; Ricardo Sorensen; Nicolas Wulffraat; Stéphane Blanche; Frederic D Bushman; Alain Fischer; Marina Cavazzana-Calvo
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

6.  Simian virus 40 minichromosomes as targets for retroviral integration in vivo.

Authors:  P M Pryciak; H P Müller; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

7.  Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core.

Authors:  D Pruss; F D Bushman; A P Wolffe
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

8.  A sensitive, quantitative assay for human immunodeficiency virus type 1 integration.

Authors:  Una O'Doherty; William J Swiggard; Deepa Jeyakumar; David McGain; Michael H Malim
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

9.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

10.  Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.

Authors:  Rick S Mitchell; Brett F Beitzel; Astrid R W Schroder; Paul Shinn; Huaming Chen; Charles C Berry; Joseph R Ecker; Frederic D Bushman
Journal:  PLoS Biol       Date:  2004-08-17       Impact factor: 8.029

View more
  79 in total

Review 1.  HIV reservoirs and strategies for eradication.

Authors:  Miranda Z Smith; Fiona Wightman; Sharon R Lewin
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

Review 2.  HIV DNA integration.

Authors:  Robert Craigie; Frederic D Bushman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 3.  Quiescent T cells and HIV: an unresolved relationship.

Authors:  Dimitrios N Vatakis; Christopher C Nixon; Jerome A Zack
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

Review 4.  HIV reservoirs and latency models.

Authors:  Matthew J Pace; Luis Agosto; Erin H Graf; Una O'Doherty
Journal:  Virology       Date:  2011-02-01       Impact factor: 3.616

5.  Chromatin reassembly factors are involved in transcriptional interference promoting HIV latency.

Authors:  Edurne Gallastegui; Gonzalo Millán-Zambrano; Jean-Michel Terme; Sebastián Chávez; Albert Jordan
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

6.  Proviruses selected for high and stable expression of transduced genes accumulate in broadly transcribed genome areas.

Authors:  Jirí Plachy; Jan Kotáb; Petr Divina; Markéta Reinisová; Filip Senigl; Jirí Hejnar
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

Review 7.  Genotoxicity of retroviral hematopoietic stem cell gene therapy.

Authors:  Grant D Trobridge
Journal:  Expert Opin Biol Ther       Date:  2011-03-07       Impact factor: 4.388

8.  GS-9822, a preclinical LEDGIN candidate, displays a block-and-lock phenotype in cell culture.

Authors:  Anne Bruggemans; Gerlinde Vansant; Mini Balakrishnan; Michael L Mitchell; Ruby Cai; Frauke Christ; Zeger Debyser
Journal:  Antimicrob Agents Chemother       Date:  2021-02-22       Impact factor: 5.191

Review 9.  Fate-Regulating Circuits in Viruses: From Discovery to New Therapy Targets.

Authors:  Anand Pai; Leor S Weinberger
Journal:  Annu Rev Virol       Date:  2017-08-11       Impact factor: 10.431

Review 10.  The effects of cocaine on HIV transcription.

Authors:  Mudit Tyagi; Jaime Weber; Michael Bukrinsky; Gary L Simon
Journal:  J Neurovirol       Date:  2015-11-16       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.